Literature DB >> 18339822

Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.

M F Vescio1, B Longo, S Babudieri, G Starnini, S Carbonara, G Rezza, R Monarca.   

Abstract

BACKGROUND: The prevalence of infection with hepatitis C virus (HCV) is higher among prison inmates compared with the general population because of the high proportion of injecting drug users (IDU).
METHODS: A meta-analysis of studies on HCV infection in the correctional system was performed. The main objective was to analyse risk factors for HCV infection and to assess HCV seroprevalence and incidence in prison.
RESULTS: Thirty studies were included in the meta-analysis on HCV prevalence. IDU were approximately 24 times more likely than non-IDU to be HCV positive. The odds ratio of being HCV positive was three times higher for inmates exposed to tattooing than those not exposed. The odds ratio among women was 1.44 compared with men.
CONCLUSIONS: The differences in HCV seroprevalence among studies can largely be explained by differences in the proportion of inmates who are IDU and partly by differences in seroprevalence among IDU in the community. Tattooing and female gender were also associated with HCV positivity. These findings should be taken into account when planning prevention activities in prisons.

Entities:  

Mesh:

Year:  2008        PMID: 18339822     DOI: 10.1136/jech.2006.051599

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  58 in total

1.  Hepatitis C and B prevalence in Spanish prisons.

Authors:  P Saiz de la Hoya; A Marco; J García-Guerrero; A Rivera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-28       Impact factor: 3.267

2.  Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities.

Authors:  Kimberly J Alvarez; Montina Befus; Carolyn T A Herzig; Elaine Larson
Journal:  J Infect Public Health       Date:  2014-08-30       Impact factor: 3.718

Review 3.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

Review 4.  Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.

Authors:  Amber Arain; Geert Robaeys
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.

Authors:  Bruno Fernandes de Oliveira Santos; Nathalie Oliveira de Santana; Alex Vianey Callado Franca
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

6.  HCV-related mortality among male prison inmates in Texas, 1994-2003.

Authors:  Amy J Harzke; Jacques G Baillargeon; Michael F Kelley; Pamela M Diamond; Karen J Goodman; David P Paar
Journal:  Ann Epidemiol       Date:  2009-05-13       Impact factor: 3.797

7.  Racial differences in HIV/AIDS discussion strategies and sexual risk behaviors among drug-abusing female criminal offenders.

Authors:  Carrie B Oser; Jennifer R Havens; Jennifer L Mooney; Michele Staton-Tindall; Hannah K Knudsen; Jamieson L Duvall; Carl G Leukefeld
Journal:  J Psychoactive Drugs       Date:  2008-12

8.  HCV in incarcerated populations: an analysis of gender and criminality on risk.

Authors:  Anne G Rhodes; Faye S Taxman; Peter D Friedmann; Karen L Cropsey
Journal:  J Psychoactive Drugs       Date:  2008-12

Review 9.  Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment.

Authors:  Rosa Zampino; Nicola Coppola; Caterina Sagnelli; Giovanni Di Caprio; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-09-28

Review 10.  Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis.

Authors:  Sarah Larney; Hannah Kopinski; Curt G Beckwith; Nickolas D Zaller; Don Des Jarlais; Holly Hagan; Josiah D Rich; Brenda J van den Bergh; Louisa Degenhardt
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.